Partnerships & Mergers

The initiative builds on the partnership that began after ADNOC appointed Burjeel Holdings as the medical operator of Al Dhannah Hospital in 2023.

The strategic collaboration aims to combine robotic technology with specialist surgical expertise to strengthen minimally invasive procedures across urology, gynaecology, and general surgery.

The new agreements build on i3’s market access programme, which has facilitated more than 760 tailored introductions and contributed to 165 partnerships, pilots and memoranda of understanding valued at more than US$19 million.

Through the partnership, PureHealth and Erth Hospitality will apply hospitality practices to non-clinical aspects of the hospital environment.

The agreement comes as Novo continues to strengthen its position in cardiometabolic medicines, where longer dosing intervals are a growing focus of research and development.

T cell engagers are designed to bring a patient’s T cells into contact with cancer cells, enabling the immune cells to attack the tumour.

The companies said the partnership will support the introduction of MetMark into US laboratories using the XpressGT platform.

Earendil, a biotechnology company operating in the US and China, will identify and develop bispecific antibody programmes based on target combinations agreed with Genentech.

The collaboration comes as pharmaceutical developers explore alternative delivery routes for biologic medicines, which can present formulation and administration challenges because of their molecular size and complexity.

The AD BMT® program at Yas Clinic Khalifa City and ADSCC manages pediatric and adult cases requiring specialized transplantation, including immune disorders, rare genetic diseases and other high risk conditions.